PubRank

Halvor Rollag

Author PubWeight™ 24.30‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Impact of genetic polymorphisms in cytomegalovirus glycoprotein B on outcomes in solid-organ transplant recipients with cytomegalovirus disease. Clin Infect Dis 2009 1.64
2 Impact of early cytomegalovirus infection and disease on long-term recipient and kidney graft survival. Kidney Int 2004 1.57
3 Pre-transplant Toxoplasma gondii seropositivity among heart transplant recipients is associated with an increased risk of all-cause and cardiac mortality. J Am Coll Cardiol 2007 1.48
4 The impact of cytomegalovirus infection and disease on rejection episodes in renal allograft recipients. Am J Transplant 2002 1.36
5 [Re: Hearing loss in children in Östfold county 2000-09]. Tidsskr Nor Laegeforen 2015 1.08
6 The clinical utility of whole blood versus plasma cytomegalovirus viral load assays for monitoring therapeutic response. Transplantation 2011 1.07
7 Cytomegalovirus resistance in solid organ transplant recipients treated with intravenous ganciclovir or oral valganciclovir. Antivir Ther 2009 1.05
8 Characterization of human cytomegalovirus uracil DNA glycosylase (UL114) and its interaction with polymerase processivity factor (UL44). J Mol Biol 2008 1.02
9 Incidence and outcomes of ganciclovir-resistant cytomegalovirus infections in 1244 kidney transplant recipients. Transplantation 2011 1.00
10 Virologic suppression measured by a cytomegalovirus (CMV) DNA test calibrated to the World Health Organization international standard is predictive of CMV disease resolution in transplant recipients. Clin Infect Dis 2013 0.92
11 Is there a link between cytomegalovirus infection and new-onset posttransplantation diabetes mellitus? Potential mechanisms of virus induced beta-cell damage. Nephrol Dial Transplant 2005 0.92
12 Reduced incidence of new-onset posttransplantation diabetes mellitus during the last decade. Transplantation 2007 0.92
13 CD11c+ dendritic cells and plasmacytoid DCs are activated by human cytomegalovirus and retain efficient T cell-stimulatory capability upon infection. Blood 2005 0.90
14 Plasmacytoid DCs regulate recall responses by rapid induction of IL-10 in memory T cells. Blood 2006 0.84
15 The impact of early cytomegalovirus infection after kidney transplantation on long-term graft and patient survival. Clin Transplant 2013 0.83
16 High ficolin-3 level at the time of transplantation is an independent risk factor for graft loss in kidney transplant recipients. Transplantation 2015 0.83
17 Cytomegalovirus infection in renal transplant recipients is associated with impaired survival irrespective of expected mortality risk. Clin Transplant 2007 0.81
18 Impact of the complement lectin pathway on cytomegalovirus disease early after kidney transplantation. Nephrol Dial Transplant 2008 0.81
19 Cytomegalovirus viremia in dried blood spots is associated with an increased risk of death in HIV-infected patients: a cohort study from rural Tanzania. Int J Infect Dis 2012 0.81
20 Human cytomegalovirus infection modulates DNA base excision repair in fibroblast cells. Virology 2006 0.79
21 Differential decay kinetics of human cytomegalovirus glycoprotein B genotypes following antiviral chemotherapy. J Clin Virol 2012 0.78
22 Valganciclovir for the prevention and treatment of CMV in solid organ transplant recipients. Expert Opin Pharmacother 2010 0.78
23 Pre-emptive therapy of CMVpp65 antigen positive renal transplant recipients with oral ganciclovir: a randomized, comparative study. Nephrol Dial Transplant 2003 0.77
24 Increased osteoprotegerin predicts poor virological outcome during anticytomegalovirus therapy in solid organ transplant recipients. Transplantation 2015 0.76
25 The chromatin remodeling factor SMARCB1 forms a complex with human cytomegalovirus proteins UL114 and UL44. PLoS One 2012 0.75
26 Viral infection in placenta relevant cells--a morphological and immunohistochemical cell culture study. APMIS 2014 0.75
27 Elevated troponin I and NT-proBNP at the time of transplantation may predict a major adverse cardiac event in the early postoperative period after renal transplantation. Transplantation 2012 0.75